Growth Metrics

Medpace Holdings (MEDP) Net Cash Flow (2016 - 2026)

Medpace Holdings filings provide 12 years of Net Cash Flow readings, the most recent being $157.7 million for Q1 2026.

  • On a quarterly basis, Net Cash Flow rose 168.53% to $157.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $209.5 million, a 525.18% increase, with the full-year FY2025 number at -$178.3 million, down 141.81% from a year prior.
  • Net Cash Flow hit $157.7 million in Q1 2026 for Medpace Holdings, down from $210.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $239.0 million in Q3 2025 to a low of -$398.1 million in Q2 2025.
  • Median Net Cash Flow over the past 5 years was $17.9 million (2023), compared with a mean of $11.5 million.
  • Biggest five-year swings in Net Cash Flow: crashed 764.14% in 2022 and later surged 4199.56% in 2023.
  • Medpace Holdings' Net Cash Flow stood at -$3.7 million in 2022, then surged by 4199.56% to $149.9 million in 2023, then tumbled by 90.33% to $14.5 million in 2024, then soared by 1355.04% to $210.9 million in 2025, then dropped by 25.22% to $157.7 million in 2026.
  • The last three reported values for Net Cash Flow were $157.7 million (Q1 2026), $210.9 million (Q4 2025), and $239.0 million (Q3 2025) per Business Quant data.